Cost-benefit thresholds are outdated, says MPs' report

By Sally E Gainsbury2008-01-10T09:00:00

The health select committee has recommended sweeping changes to the way the National Institute for Health and Clinical Excellence assesses what drugs and treatments should be available on the NHS.

You need to be a subscriber to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All HSJ news by sector, topic & region
Breaking News announcements
App for mobile and offline reading
Comment and Daily Insights newsletters
Regional roundup newsletters

to HSJ

Already a subscriber? Sign into your account here